Home/Health And Wellness/

CureVac COVID-19 vaccine hits just 48% efficacy in final analysis

Jonny Smith Reply 10:09 A+ A-

CureVac COVID-19 vaccine hits just 48% efficacy in final analysis

German biotech company CureVac announced its COVID-19 vaccine demonstrated 48% efficacy against COVID-19 of any severity in a final readout of late-stage trial data.

Health And Wellness, Health Blogs, Health Care, Health Drinks, Health Drinks for Kids, Health is Wealth, Health Tips

Post a Comment

:noprob:

:smile:

:shy:

:trope:

:sneered:

:happy:

:escort:

:rapt:

:love:

:heart:

:angry:

:hate:

:sad:

:sigh:

:disappointed:

:cry:

:fear:

:surprise:

:unbelieve:

:shit:

:like:

:dislike:

:clap:

:cuff:

:fist:

:ok:

:file:

:link:

:place:

:contact:

Older PostWHO decision challenges West to recognize Chinese vaccines

Newer PostHow does the Delta variant differ from original strain?

Copyright (c) 2018 Healthell - Daily Viral Health News.